Major Depressive Disorder News and Research

RSS

Major Depressive Disorder (MDD) is a psychiatric condition characterized by depressed mood or anhedonia (significant loss of interest or pleasure). The condition affects more than 15.7 million adults and approximately 3 million adolescents (aged 13 to 17 years) in the USA each year.

Study of Millennials highlights social media behaviors linked with major depression

Certain social media factors were linked with major depressive disorder (MDD) in a Journal of Applied Biobehavioural Research study of Millennials.

9 Jan 2019

Experts analyze data that can guide antidepressant discontinuation

There has been a lot of attention to problems patients face in discontinuing antidepressant drugs. However, there appear to be few indications, particularly in guidelines and reviews.

13 Dec 2018

Obsessive-compulsive disorder may protect individuals from obesity

A new study led by Amitai Abramovitch, assistant professor in the Department of Psychology at Texas State University, shows that individuals with obsessive-compulsive disorder (OCD) are significantly less likely to become overweight or obese.

12 Dec 2018

Study: Self-guided, internet-based therapy platforms effectively reduce depression

In a sweeping new study, Indiana University psychologists have found that a series of self-guided, internet-based therapy platforms effectively reduce depression.

11 Dec 2018

New tool swiftly provides accurate measure of patients' cognitive difficulties

A new tool, developed by researchers from the University of Adelaide, will assist clinicians to assess people suffering from major depressive disorder.

11 Dec 2018

Veterans who suffered multiple traumatic brain injuries are at greater risk for suicide

A new Veterans Affairs study finds that post-9-11 veterans with a history of repeated traumatic brain injuries--versus none--are at much greater risk for considering suicide.

28 Nov 2018

Pharmacogenetic tests don't provide much information for prescribing antidepressants or antipsychotics

Pharmacogenetic tests are marketed as an aid to psychiatrists in selecting the antidepressant or antipsychotic medication that will work best in individual patients, based on their genetic makeup.

21 Nov 2018

Higher body mass index could cause depression even without health problems

A largescale genomic analysis has found the strongest evidence yet that being overweight causes depression, even in the absence of other health problems.

13 Nov 2018

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

Supervised aerobic exercise can support major depression treatment

An analysis of randomized controlled clinical trials indicates that supervised aerobic exercise has large antidepressant treatment effects for patients with major depression. The systematic review and meta-analysis is published in Depression and Anxiety.

18 Oct 2018

Antidepressant treatment may lead to improvements in sleep quality of patients with depression

In a study of 15 patients affected by major depressive disorder and complaining of insomnia, initiating treatment with vortioxetine for their depressive symptoms led to significant improvements in subjective sleep quality and daytime sleepiness.

17 Oct 2018

Research provides a more complete picture of suffering caused by terrorist attacks

Terrorist attacks injure far more people than they kill, leaving victims with lost limbs, hearing loss, respiratory disease, depression and other issues. But little research has measured the impact of that damage beyond the number of people who are hurt.

15 Oct 2018

DNA of people with depression, trauma is biologically older than healthy individuals

DNA from people who suffer from major depression is biologically older than that of healthy people by on average 8 months, suggesting that they are biologically older than their corresponding calendar age.

8 Oct 2018

Experts warn health care providers to slow down in allowing smart pill in patient care settings

Enthusiasm for an emerging digital health tool, the smart pill, is on the rise but researchers at the University of Illinois at Chicago have published a paper in the American Journal of Bioethics that cautions health care providers and policymakers to slow down when it comes to allowing this technology in patient care settings.

21 Sep 2018

Childhood adversity associated with impaired social cognition in adults with major psychiatric disorders

A new report published in European Psychiatry identified a significant association between childhood adversity and impaired social cognitive functioning among adults diagnosed with major psychiatric disorders.

12 Sep 2018

WVU researcher works to improve treatment access for rural depressed patients

Rates of depression tend to be higher in rural areas than in urban ones, yet rural residents may have a harder time accessing mental health care. Driving to see a psychiatrist or counselor may take hours, and wait times for an appointment may take months.

6 Sep 2018

New guidelines for evaluation and treatment of perimenopausal depression

It is well-recognized that women are at increased risk of depression during postpartum when hormone levels are changing, but the risk of depression associated with perimenopause -- the time right before menopause when female hormones are in decline -- remains under-recognized and clinical recommendations on how to diagnose and treat this kind of depression in women have been lacking until now.

5 Sep 2018

Looking deep inside the brain to accurately diagnose bipolar disorder and depression

New research has found that neurons deep inside the brain could hold the key to accurately diagnosing bipolar disorder and depression.

4 Sep 2018

Study explores how social networks affect smoking outcomes in people with serious mental illness

People with serious mental illness have a reduced life expectancy of up to 25 years compared to the general population

24 Aug 2018

BrainsWay receives FDA clearance for Deep TMS system to treat adults with obsessive-compulsive disorder

BrainsWay Ltd., the parent company of BrainsWay USA, Inc., and a global leader in the advanced non-invasive treatment of brain disorders, today announces that it has received De Novo clearance from the U.S. Food and Drug Administration (FDA) for its deep transcranial magnetic stimulation (Deep TMS) system for the treatment of obsessive-compulsive disorder (OCD) in adults.

22 Aug 2018